SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    U.S. Preventive Services Task Force. Screening for breast cancer update 2002. Washington, DC: U.S. Preventive Services Task Force, 2002.
  • 2
    Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 347360.
  • 3
    Nystrom L, Rutqvist LE, Wall S, et al, Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993; 341: 973978.
  • 4
    Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992; 30: 187210.
  • 5
    Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990; 335: 241246.
  • 6
    Peek ME, Han JH. Disparities in screening mammography. Current status, interventions and implications. J Gen Intern Med. 2004; 19: 184194.
  • 7
    Rakowski W, Breen N, Meissner H, et al. Prevalence and correlates of repeat mammography among women aged 55–79 in the year 2000. Prev Med. 2004; 39: 110.
  • 8
    Ostbye T, Greenberg GN, Taylor DH Jr., Lee AM. Screening mammography and Pap tests among older American women 1996–2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). Ann Fam Med. 2003; 1: 209217.
  • 9
    Blanchard K, Colbert JA, Puri D, et al. Mammographic screening: patterns of use and estimated impact on breast cancer survival. Cancer. 2004; 101: 495507.
  • 10
    Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev. 2003; 12(11 Pt 1): 11821187.
  • 11
    Population Research Institute, Penn State University. 2000 National Health Survey (cancer control module). Available from URL: http://www.pcp.psu.edu [accessed August 16, 2005].
  • 12
    American Cancer Society. ACS cancer detection guidelines. Available from URL: http://www.cancer.org/docroot/PED/content/PED_2_3X_ACS_Cancer_Detection_Guidelines_36.asp [accessed August 16, 2005].
  • 13
    Carney PA, Poplack SP, Wells WA, Littenberg B. The New Hampshire Mammography Network: the development and design of a population-based registry.[see comment]. AJR Am J Roentgenol. 1996; 167: 367372.
  • 14
    Poplack SP, Tosteson AN, Grove MR, Wells WA, Carney PA. Mammography in 53,803 women from the New Hampshire Mammography Network. Radiology. 2000; 217: 832840.
  • 15
    Cronin KA, Yu B, Krapcho M, et al. Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005; 16: 701712.
  • 16
    Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997; 169: 10011008.
  • 17
    Coughlin SS, Thompson TD, Hall HI, Logan P, Uhler RJ. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998–1999. Cancer. 2002; 94: 28012812.
  • 18
    Strzelczyk JJ, Dignan MB. Disparities in adherence to recommended follow-up on screening mammography: interaction of sociodemographic factors. Ethn Dis. 2002; 12: 7786.
  • 19
    Centers for Disease Control. Behavioral Risk Factor Survey web site. Available at URL: http://www.cdc.gov/nccdphp/aag/aag_brfss.htm [accessed August 16, 2005].
  • 20
    Lagerlund M, Widmark C, Lambe M, Tishelman C. Rationales for attending or not attending mammography screening—a focus group study among women in Sweden. Eur J Cancer Prev. 2001; 10: 429442.
  • 21
    Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME. Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer. 2002; 95: 219227.
  • 22
    Aro AR, de Koning HJ, Absetz P, Schreck M. Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat. 2001; 70: 145153.
  • 23
    Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med. 2001; 23: 292300.
  • 24
    Meystre-Agustoni G, Paccaud F, Jeannin A, Dubois-Arber F. Anxiety in a cohort of Swiss women participating in a mammographic screening programme. J Med Screen. 2001; 8: 213219.
  • 25
    Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME. Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer. 2002; 95: 21927.
  • 26
    Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK. The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev. 2002; 11: 5971.
  • 27
    Carney PA, Harwood BG, Greene MA, Goodrich ME. Impact of a telephone counseling intervention on transitions in stage of change and adherence to interval mammography screening. Cancer Causes Control, 2005; 16: 799807.
  • 28
    Clark MA, Rakowski W, Ehrich B, et al. The effect of a stage-matched and tailored intervention on repeat mammography (1). Am J Prev Med. 2002; 22: 17.
  • 29
    Taplin SH, Barlow WE, Ludman E, et al. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. J Natl Cancer Inst. 2000; 92: 233242.